Indegene IPO vs Kronox Lab Sciences IPO

Comparision between Indegene IPO and Kronox Lab Sciences IPO.

IPO Details

Indegene IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Kronox Lab Sciences IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Indegene IPO	Kronox Lab Sciences IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	Kotak Mahindra Capital Company Limited Citigroup Global Markets India Private Limited J.P. Morgan India Private Limited Nomura Financial Advisory And Securities (India) Pvt Ltd	Pantomath Capital Advisors Pvt Ltd
Registrar	Link Intime India Private Ltd	Kfin Technologies Limited
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Indegene IPO is up to ₹1,841.76 Cr whereas the issue size of the Kronox Lab Sciences IPO is up to ₹130.15 Cr. The final issue price of Indegene IPO is ₹452.00 per share and of Kronox Lab Sciences IPO is ₹136.00 per share.

	Indegene IPO	Kronox Lab Sciences IPO
Face Value	₹2 per share	₹10 per share
Issue Price (Lower)	₹430.00 per share	₹129.00 per share
Issue Price (Upper)	₹452.00 per share	₹136.00 per share
Issue Price (Final)	₹452.00 per share	₹136.00 per share
Discount (Retail)
Discount (Employee)	₹30.00 per share
Market Lot Size	33 shares	110 shares
Fresh Issue Size	1,68,14,159 shares
Fresh Issue Size (Amount)	up to ₹760.00 Cr
OFS Issue Size	2,39,32,732 shares	95,70,000 shares
OFS Issue Size (Amount)	up to ₹1,081.76 Cr	up to ₹130.15 Cr
Issue Size Total	4,07,46,891 shares	95,70,000 shares
Issue Size Total (Amount)	up to ₹1,841.76 Cr	up to ₹130.15 Cr

IPO Timetable

Indegene IPO opens on May 06, 2024, while Kronox Lab Sciences IPO opens on Jun 03, 2024. The closing date of Indegene IPO and Kronox Lab Sciences IPO is May 08, 2024, and Jun 05, 2024, respectively.

	Indegene IPO	Kronox Lab Sciences IPO
Anchor Bid Date	May 03, 2024	May 31, 2024
Issue Open	May 06, 2024	Jun 03, 2024
Issue Close	May 08, 2024	Jun 05, 2024
Basis Of Allotment (Tentative)	May 09, 2024	Jun 06, 2024
Initiation of Refunds (Tentative)	May 10, 2024	Jun 07, 2024
Credit of Share (Tentative)	May 10, 2024	Jun 07, 2024
Listing date (Tentative)	May 13, 2024	Jun 10, 2024
Anchor Lockin End date 1	Jun 08, 2024	Jul 06, 2024
Anchor Lockin End date 2	Aug 07, 2024	Sep 04, 2024

Financials

Indegene IPO P/E ratio is 37.78, as compared to Kronox Lab Sciences IPO P/E ratio of 30.37.

Indegene IPO

Kronox Lab Sciences IPO

Financial

Indegene Limited Financial Information (Restated Consolidated)

Indegene Limited's revenue increased by 39.85% and profit after tax (PAT) rose by 63.43% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended	31 Dec 2023	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	2,518.15	2,203.87	1,353.47	596.04
Revenue	1,969.75	2,364.10	1,690.50	996.92
Profit After Tax	241.90	266.10	162.82	149.41
Net Worth	1,327.00	1,063.72	763.90	324.51
Reserves and Surplus	1,282.65	1,019.43	763.55	324.19
Total Borrowing	399.33	394.34	18.24	24.76
Amount in ₹ Crore

Kronox Lab Sciences Limited Financial Information (Restated)

Kronox Lab Sciences Limited's revenue increased by 16.99% and profit after tax (PAT) rose by 21.94% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended	31 Dec 2023	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	66.96	54.03	56.79	37.65
Revenue	68.44	97.50	83.34	63.24
Profit After Tax	15.47	16.62	13.63	9.73
Net Worth	60.28	44.68	40.35	26.81
Reserves and Surplus	15.56	7.58	40.11	26.57
Total Borrowing			0.64	0.01
Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

30.71%

99.98%

Promoter Shareholding (Post-Issue)

74.21%

P/E Ratio

37.78

30.37

Market Cap

₹10814.07 Cr.

₹504.61 Cr.

ROE

25.66%%

ROCE

33.15%%

Debt/Equity

0.3

EPS

₹11.96

₹4.48

RoNW

18.23%%

25.66%%

Shares Offered

In the Indegene IPO retail investors (RII) are offered 1,41,64,620 shares while in Kronox Lab Sciences IPO retail investors are offered 1,41,64,620 shares. Qualified institutional buyers (QIB) are offered 80,94,069 shares in Indegene IPO and 19,14,000 shares in Kronox Lab Sciences IPO.

	Indegene IPO	Kronox Lab Sciences IPO
Anchor Investor Reserveration	1,21,41,102 shares	28,71,000 shares
Market Maker Reserveration
QIB	80,94,069 shares	19,14,000 shares
NII	60,70,552 shares	14,35,500 shares
RII	1,41,64,620 shares	33,49,500 shares
Employee	2,96,209 shares	0 shares
Others
Total	2,86,25,450 shares	66,99,000 shares

Bids Received (Subscription)

Indegene IPO subscribed 70.30x in total, whereas Kronox Lab Sciences IPO subscribed 117.25x.

	Indegene IPO	Kronox Lab Sciences IPO
QIB (times)	192.72x	89.03x
NII (times)	55.91x	301.92x
Big NII (times)	62.23x	322.26x
Small NII (times)	43.26x	261.22x
RII (times)	7.86x	54.24x
Employee (times)	6.62x
Other (times)
Total (times)	70.30x	117.25x

Compare with others

Indegene IPO	Kronox Lab Sciences IPO
Kronox Lab Sciences IPO	Vraj Iron and Steel IPO
Awfis Space Solutions IPO	Aasaan Loans IPO
Go Digit IPO	Stanley Lifestyles IPO
Aadhar Housing Finance IPO	DEE Piping Systems IPO
TBO Tek IPO	ixigo IPO
JNK India IPO	Awfis Space Solutions IPO
VI FPO	Go Digit IPO
Bharti Hexacom IPO	Aadhar Housing Finance IPO
SRM Contractors IPO	TBO Tek IPO
Popular Vehicles & Services IPO	Indegene IPO

Comments

Add a public comment...